Literature DB >> 8131447

Elevated D dimer in the lungs and blood of patients with sarcoidosis.

R L Perez1, A Duncan, R L Hunter, G W Staton.   

Abstract

The hypothesis of this study was that D dimer, a specific degradation product of cross-linked fibrin, would be increased in the bronchoalveolar lavage (BAL) fluids of patients with sarcoidosis and that it would be related to other BAL parameters of disease activity. Eight of 10 sarcoidosis patients but none of 18 healthy volunteers had detectable BAL D dimer by enzyme immunoassay. Autoradiography revealed the presence of fibrinogen and D dimer in the BAL fluids from sarcoidosis patients. Bronchoalveolar lavage D dimer levels in sarcoidosis patients correlated with total BAL cells per milliliter, lymphocytes per milliliter, and total protein level, but not macrophages per milliliter. The D dimer in the BAL fluids from sarcoidosis patients did not correlate with D dimer in the blood. Our findings indicate that BAL D dimer parallels directly the lymphocytic alveolitis that characterizes pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131447     DOI: 10.1378/chest.103.4.1100

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

2.  Sarcoidosis as a risk factor for venous thromboembolism.

Authors:  Anna Goljan Geremek; Witold Tomkowski; Marcin Geremek; Elżbieta Puścińska; Grzegorz Małek; Adam Nowiński; Michal Bednarek; Paweł Śliwiński
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua J Solomon; David Sprunger; Kevin K Brown
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

4.  Sarcoidosis: clinical mimicry of pulmonary embolism.

Authors:  Omar Nasher; David A Boldy
Journal:  BMJ Case Rep       Date:  2013-12-12

Review 5.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

6.  Case Review of Sarcoidosis Resembling Sjogren's Syndrome.

Authors:  Yuhanisa Ahmad; Nur Shuhaila Shahril; Heselynn Hussein; Mohd Shahrir Mohamed Said
Journal:  J Clin Med Res       Date:  2010-12-11

7.  Venous Leg Ulcer in a Sarcoidosis Patient: A Case Report.

Authors:  Jungyoon Ohn; Sang Young Byun; In Su Kim; Kyoung Chan Park
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

8.  Association Between Sarcoidosis and Risk of Venous Thromboembolism: A Retrospective Chart Review.

Authors:  Ali Kassem; Loai Dahabra; Ahmad Abou Yassine; Marc Assaad; Marwah Muhammad; Dany El-Sayegh
Journal:  Cureus       Date:  2022-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.